FIELD: genetic engineering, molecular biology, biochemistry.
SUBSTANCE: invention proposes a novel synthetic gene encoding green fluorescent protein. The proposed gene is characterized by change of non-preferable or less preferable codons for preferable codons. The preferable codons are represented by the following group: GCC, CGC, GAC, TGC, CAG, GGC, CAC, ATC, CTG, AAG, CCC, TTC, AGC, ACC, TAC and AGG. Non-preferable codons represent the remained codons. The new synthetic gene is characterized by ability to express green fluorescent protein in the level 110-1 000% of the natural gene expression. Also, invention proposes a method for preparing the synthetic gene encoding green fluorescent protein. Method involves determination of non-preferable or less preferable codons in the natural gene and change one of some codons for preferable codons encoding the same amino acid as changing codons. Invention proposes also expressing vector comprising the synthetic gene and a method for preparing mammalian cultured cell line carrying the synthetic gene that involves the transformation of cells with expressing vector. The proposed invention can be used for industrial preparing the necessary proteins and for carrying out the genetic therapy also.
EFFECT: improved preparing method, valuable biological and medicinal properties of gene and protein.
15 cl, 21 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING A LINE OF HUMANIZED MICE CONTAINING 3974insT INSERTION IN THE mGrin2a GENE (MICE GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON-1), LEADING TO PREMATURE TERMINATION OF TRANSLATION OF THE grin2a PROTEIN | 2021 |
|
RU2764650C1 |
ARTIFICIAL GENES CODING EV.CTL AND EV.Th PROTEINS-IMMUNOGENS, RECOMBINANT PLASMID DNA pEV.CTL AND EV.Th, PROVIDING EXPRESSION OF ARTIFICIAL GENES, AND ARTIFICIAL T-CELL POLYEPITOPE PROTEINS-IMMUNOGENS EV.CTL AND EV.Th CONTAINING EPITOPES OF EBOLA VIRUS ANTIGENS, USED TO CREATE AN EBOLA VIRUS VACCINE | 2018 |
|
RU2713723C1 |
METHOD FOR PRODUCING CHEMICAL PRODUCTS OF SUBTLE SYNTHESIS USING CORYNEBACTERIUM SECRETING MODIFIED a-1,6-GLUCOSIDASES | 2018 |
|
RU2763317C2 |
ANTIBODY FOR TREATMENT OF AUTOIMMUNE DISEASES | 2017 |
|
RU2781148C2 |
ANTIBODY TO HUMAN CD73 | 2017 |
|
RU2754058C2 |
CODON-OPTIMISED HAIPL1-ENCODING NUCLEOTIDE SEQUENCE AND EXPRESSION VECTOR CONTAINING SAID SEQUENCE | 2021 |
|
RU2785621C1 |
C5 ANTIBODY AND METHOD FOR PREVENTING AND TREATING COMPLEMENT-RELATED DISEASES | 2014 |
|
RU2663349C2 |
ANTIBODY AGAINST HUMAN FN14 | 2019 |
|
RU2787044C2 |
METHOD FOR OBTAINING A LINE OF HUMANISED MICE, TRANSGENIC BY hACE2 | 2020 |
|
RU2757114C1 |
NUCLEOTIDE SEQUENCE ENCODING β-N-ACETYLHEXOZAAMINIDASE AGGREGATIBACTER ACTINOMYCETEMCOMITANS AND GENETIC STRUCTURES CONTAINING IT | 2021 |
|
RU2789544C1 |
Authors
Dates
2004-07-27—Published
1997-09-18—Filed